NCT02613572View on ClinicalTrials.gov

Alpha Lipoic Acid in Geographic Atrophy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 15, 2019

Study Completion Date

March 1, 2019

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

alpha lipoic acid

DRUG

Placebo

Trial Locations (5)

19104

Scheie Eye Institute of the University of Pennsylvania, Philadelphia

52242

University of Iowa Hospitals and Clinics, Department of Ophthalmology & Visual Sciences, Iowa City

97210

Retina Northwest, P.C., Portland

97401

Oregon Regina. LLP, Eugene

07666

NJ Retina, Teaneck

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT02613572 - Alpha Lipoic Acid in Geographic Atrophy | Biotech Hunter | Biotech Hunter